TUMORS, NEUROENDOCRINE

Clinical trials for TUMORS, NEUROENDOCRINE explained in plain language.

Never miss a new study

Get alerted when new TUMORS, NEUROENDOCRINE trials appear

Sign up with your email to follow new studies for TUMORS, NEUROENDOCRINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Your genes could dictate your cancer drug dose

Disease control Recruiting now

This study is testing whether adjusting the dose of a cancer drug (belinostat) based on a patient's specific genetics can make treatment safer and more effective. It is for adults with aggressive neuroendocrine cancers. Participants receive a combination of three drugs, with the …

Matched conditions: TUMORS, NEUROENDOCRINE

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 17, 2026 13:09 UTC

TUMORS, NEUROENDOCRINE

Get alerted when new TUMORS, NEUROENDOCRINE trials appear

Your genes could dictate your cancer drug dose